O’Sullivan, Ciara C.
Irshad, Sheeba
Wang, Zheyu
Tang, Zhuojun
Umbricht, Christopher
Rosner, Gary L.
Christianson, Mindy S.
Stearns, Vered
Smith, Karen Lisa
Funding for this research was provided by:
Centers for Disease Control and Prevention (U58DP005410)
NIH/NCI (P30CA006973)
Article History
Received: 16 December 2019
Accepted: 29 February 2020
First Online: 11 March 2020
Compliance with ethical standards
:
: Ciara C. O’Sullivan has received research support from Lilly. Gary L. Rosner owns stock in Johnson & Johnson and Novartis. Gary L. Rosner is a member of an independent data monitoring committee for Novartis. Vered Stearns has received institutional research support from Abbvie, Biocept, Pfizer, Novartis, Medimmune, and Puma Biotechnology. Vered Stearns has served as a consultant for Iridium Therapeutics, Inc. Vered Stearns is a member of a data safety monitoring board for Immunomedics, Inc. Karen Lisa Smith’s spouse with stock ownership in ABT Labs and Abbvie. Karen Lisa Smith has received research support from CancerIncite and Pfizer. The following authors declare that they have no conflicts of interest: Sheeba Irshad, Zheyu Wang, Zhuojun Tang, Christopher Umbricht and Mindy S. Christianson.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. We obtained approval from the Johns Hopkins (JH) institutional review board (IRB) to conduct this retrospective study.